ArticleOphthalmology science

Double-Masked, Vehicle-Controlled, Randomized, Phase II Study of the Ocular Hypotensive Activity and Safety of VVN539 Ophthalmic Solution.

David Wirta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.